STORY FROM: Drugs & Medical Devices
N.J. High Court Refuses to Review Reversal of $25.1 Million Accutane Verdict
July 24, 2018
NEWARK, N.J. — The New Jersey Supreme Court will not review an appellate court’s reversal of a $25.1 million Accutane verdict in a case in which an Alabama man claims the acne drug caused his inflammatory bowel disease.
Pursuant to an order released on July 23, the plaintiff’s failure-to-warn claims will be retried in the Atlantic County Superior Court on the issues of causation and learned intermediary.
Alabama resident Andrew McCarrell sued Hoffman-La Roche, alleging that he developed IBD as a result of taking Accutane when he was in his early 20s. Shortly after discontinuing his use of the drug, ...
Associated Law Firms
Beggs & Lane
Covington & Burling
Dughi Hewit & Domalewski
Hook & Bolton